Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 11, 2015, Pages 2607-2616

  Wang, Jie ^a   Guo, Tao ^a   Peng, Qi Sheng ^b   Yue, Shou Wei ^a   Wang, Shuang Xi ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Ageing; Berberine; Blood pressure; Transient receptor potential vanilloid 4; Vascular smooth muscle cells; Vascular stiffness

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN E; BERBERINE; DEOXYCORTICOSTERONE ACETATE; RN 1734; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR ANTAGONIST; TRPV4 PROTEIN, HUMAN; VANILLOID RECEPTOR;

AGING; ANIMAL EXPERIMENT; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GENE INACTIVATION; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOVASCULAR DISEASES; DRUG EFFECTS; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY;

AGING; ANIMALS; BERBERINE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HYPERTENSION; MICE; ORGAN CULTURE TECHNIQUES; TRPV CATION CHANNELS; VASCULAR STIFFNESS; VASODILATION;

EID: 84945306672     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12645     Document Type: Article

References (35)

1. Affuso F, Mercurio V, Fazio V, et al. Cardiovascular and metabolic effects of Berberine. World J Cardiol. 2010; 2: 71-7.
2. Mokhber-Dezfuli N, Saeidnia S, Gohari AR, et al. Phytochemistry and pharmacology of berberis species. Pharmacogn Rev. 2014; 8: 8-15.
3. Wang Q, Zhang M, Liang B, et al. Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. PLoS ONE. 2011; 6: e25436.
4. Lau CW, Yao XQ, Chen ZY, et al. Cardiovascular actions of berberine. Cardiovasc Drug Rev. 2001; 19: 234-44.
5. Ratz PH, Berg KM, Urban NH, et al. Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. Am J Physiol Cell Physiol. 2005; 288: C769-83.
6. Wang J, Thio SS, Yang SS, et al. Splice variant specific modulation of CaV1.2 calcium channel by galectin-1 regulates arterial constriction. Circ Res. 2011; 109: 1250-8.
7. 2+ in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2011; 301: G138-47.
8. Wang F, Zhou HY, Zhao G, et al. Inhibitory effects of berberine on ion channels of rat hepatocytes. World J Gastroenterol. 2004; 10: 2842-5.
9. Wang S, Liang B, Viollet B, et al. Inhibition of the AMP-activated protein kinase-alpha2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice. Hypertension. 2011; 57: 1010-7.
10. + exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain. Cardiovasc Res. 2008; 80: 255-62.
11. + exchanger inhibitor prevented endothelial dysfunction induced by high glucose. J Cardiovasc Pharmacol. 2005; 45: 586-90.
12. Wang SX, Xiong XM, Song T, et al. Protective effects of cariporide on endothelial dysfunction induced by high glucose. Acta Pharmacol Sin. 2005; 26: 329-33.
13. Liang B, Wang S, Wang Q, et al. Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of AMP-activated protein kinase-alpha2 in vivo. Arterioscler Thromb Vasc Biol. 2013; 33: 595-604.
14. Du YH, Guan YY, Alp NJ, et al. Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. Circulation. 2008; 117: 1045-54.
15. Han Y, Wang Q, Song P, et al. Redox regulation of the AMP-activated protein kinase. PLoS ONE. 2010; 5: e15420.
16. Liang KW, Yin SC, Ting CT, et al. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells. Eur J Pharmacol. 2008; 590: 343-54.
17. Wang S, Zhang M, Liang B, et al. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res. 2010; 106: 1117-28.
18. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003; 83: 1325-58.
19. Nagy Z, Kolev K, Csonka É, et al. Contraction of human brain endothelial cells induced by thrombogenic and fibrinolytic factors: an in vitro cell culture model. Stroke. 1995; 26: 265-70.
20. Greif DM, Sacks DB, Michel T. Calmodulin phosphorylation and modulation of endothelial nitric oxide synthase catalysis. Proc Natl Acad Sci USA. 2004; 101: 1165-70.
21. Qi MY, Feng Y, Dai DZ, et al. CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity. Acta Pharmacol Sin. 2010; 31: 165-74.
22. Firth AL, Remillard CV, Yuan JX. TRP channels in hypertension. Biochim Biophys Acta. 2007; 1772: 895-906.
23. 2+ events, and IKCa channels, reducing arteriolar tone. Proc Natl Acad Sci USA. 2012; 109: 18174-9.
24. Filosa JA, Yao X, Rath G. TRPV4 and the regulation of vascular tone. J Cardiovasc Pharmacol. 2013; 61: 113-9.
25. Xu J, Shi GP. Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta. 2014; 1842: 2106-19.
26. O'Rourke MF, Mancia G. Arterial stiffness. J Hypertens. 1999; 17: 1-4.
27. Dai DZ, Hu HJ, Zhao J, et al. Blockade of L-type calcium channel in myocardium and calcium-induced contractions of vascular smooth muscle by CPU 86017. Acta Pharmacol Sinica. 2004; 25: 416-23.
28. Everaerts W, Nilius B, Owsianik G. The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog Biophys Mol Biol. 2010; 103: 2-17.
29. Sukumaran SV, Singh TU, Parida S, et al. TRPV4 channel activation leads to endothelium-dependent relaxation mediated by nitric oxide and endothelium-derived hyperpolarizing factor in rat pulmonary artery. Pharmacol Res. 2013; 78: 18-27.
30. Zhang DX, Mendoza SA, Bubolz AH, et al. Transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo. Hypertension. 2009; 53: 532-8.
31. Ma X, Du J, Zhang P, et al. Functional role of TRPV4-KCa2.3 signaling in vascular endothelial cells in normal and streptozotocin-induced diabetic rats. Hypertension. 2013; 62: 134-9.
32. 2+ signaling complex with ryanodine receptors and BKCa channels. Circ Res. 2005; 97: 1270-9.
33. Wang Y, Huang Y, Lam KS, et al. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res. 2009; 82: 484-92.
34. Ko WH, Yao XQ, Lau CW, et al. Vasorelaxant and antiproliferative effects of berberine. Eur J Pharmacol. 2000; 399: 187-96.
35. + channels in cardiac myocytes. Eur J Pharmacol. 1996; 316: 307-15.